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ABSTRACT 
The degradation of structural collagen contributes to the characteristic appearance of wrinkles. The anti-wrinkle effects 
of a variety of substances have been studied, but the potential anti-wrinkle effects of topical applications of collagen for 
periorbital wrinkles have not been investigated. To evaluate the effects of topical application of succinylated atelocol-
lagen on periorbital wrinkles and to compare the results of treatment with adenosine, a clinical study on Korean partici-
pants was carried out. Each participant’s right or left periorbital area was treated with either a solution containing suc-
cinylated atelocollagen and adenosine or a solution containing only succinylated atelocollagen for two months. A pla-
cebo solution was applied to the opposite periorbital area of each patient’s face for two months. Based on objective and 
subjective measurements of clinical improvement, the assessment scores for treated sites were statistically significantly 
higher than scores for placebo sites after two months of treatment. Analysis of silicone casts of periorbital wrinkles 
demonstrated partial effects of succinylated atelocollagen on periorbital wrinkles. However, we did not observe any 
effects of adenosine on periorbital wrinkles. Succinylated atelocollagen may be an effective treatment option for perior- 
bital wrinkles, but further studies including a longer treatment period and larger subject group are needed to verify these 
results. 
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1. Introduction 
Skin aging manifests as changes in skin thickness, color, 
elasticity, vascular dilatation and wrinkles. Epidermal 
atrophy and the degeneration of dermal collagen and 
elastic fibers lead to the formation of wrinkles and fine 
lines. Due to mimetic muscle movement and the remod-
eling of bony tissues, deeper and more prominent wrin-
kles occur with aging [1]. Sunlight, smoking and pollut-
ants increase the production of collagenase, and an en-
zyme breaks down collagen through a signal transduction 
cascade, resulting in the acceleration of wrinkle forma-
tion [2]. In the field of dermatology, there is increasing 
demand for effective, convenient medications and cos-
metics that prevent or treat wrinkles and that have few 
side effects.  
Studies on a variety of agents that may be effective for 
treating and preventing wrinkles are ongoing, with reti- 
noids, vitamin C and adenosine considered especially ef- 
fective [1]. Several anti-oxidants, including vitamin E, 
ferulic acid, co-enzyme Q10, idebenone, green tea, sily- 
marin and pycnogenol, are incorporated into skin care 
products [1]. Asiaticoside, phosphatidylserine, ginseng 
saponins isolated from red ginseng, and K6PC-5, a novel 
sphingosine kinase activator, are under continued study, 
having demonstrated antioxidative effects and wrinkle 
improvement [3-5]. However, the potential anti-wrinkle 
effects of topical applications of collagen, a component 
of the dermis, have not been investigated.  
Collagen is a fundamental component of the dermis, 
and type I collagen makes up 80% of the collagen in the 
skin [6]. As aging progresses, fragmented type I collagen 
fibrils become prominent and disrupt the mechanical 
properties of the skin, leading to wrinkle formation [7]. 
Therefore, supplying collagen, the major component of 
the skin’s extracellular substrate, may offer an effective 
fundamental treatment for wrinkles. However, collagen  
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is insoluble in neutral solution and has a large molecular 
weight (300 kDa), so it is not sure that collagen pene-
trates into the skin. In addition, when collagen is kept at 
room temperature, it becomes denatured and loses its 
triple helix structure, rendering it ineffective. Due to 
these limitations, direct injections of small collagen par-
ticles dispersed in distilled water are often used by der-
matolo- gists rather than topical applications.  
Among the succinylated atelocollagen used in this re- 
search, the telopeptide on both ends, which causes im- 
mune reactions, was eliminated to minimize the immune 
reactions in human body. Furthermore, the atelocollagen 
was treated with succinic anhydride to electrically induce 
an anionic status that improves solubility in water or 
neutral solution. We performed a double blind, random-
ized, prospective, split-face clinical study on Korean par-
ticipants with periorbital wrinkles to evaluate the effects 
of topical application of succinylated atelocollagen on 
periorbital wrinkles. We compared the results of topical 
atelocollagen treatment to the results of treatment with 
adenosine, which is an approved anti-wrinkle treatment 
ingredient. 
2. Methods 
2.1. Patients 
The study protocol was approved by the Institutional 
Review Board of Severance Hospital, Yonsei University 
College of Medicine, Seoul, Korea and informed consent 
was obtained from each participant. Thirty-two female 
participants (mean age 49.1; age range 32 - 59 years) 
with periorbital wrinkles were enrolled in a double-blind, 
randomized, prospective, split-face clinical study. The 
participants were stratified based on a baseline facial 
grading scale, ranging from 0 to 5 (0, no evidence of 
lines or wrinkles to 5, many deep lines below the eye 
with several coarse wrinkles that extend into the cheek 
area) [8]. Exclusion criteria included a history of keloid 
scarring or other skin diseases, any laser procedures or 
isotretinoin use within six months of study initiation, 
pregnancy, or systemic diseases that are known to affect 
metabolism. Patients with facial scale grades of 0 or 1 
were also excluded.  
2.2. Treatments 
One side of each participant’s face (periorbital area) was 
randomly assigned to be treated with either a solution 
containing succinylated atelocollagen and adenosine (so-
dium hyaluronate, L-lysine, succinylated atelocollagen, 
adenosine) (Group A), or a solution containing only suc-
cinylated atelocollagen (sodium hyaluronate, L-lysine, 
succinylated atelocollagen) (Group B). A placebo (so-
dium hyaluronate, L-lysine) solution (Group P) was ap-
plied to the other side of each patient’s face. Composi-
tions of the test and placebo solutions are summarized in 
Table 1. Subjects were instructed to apply the treatment 
and placebo solutions twice a day for two months on 
each side of the face in the periorbital area. Patients were 
instructed to avoid the use of any bleaching or anti- 
wrinkle agents during the course of treatment. Skin biop- 
sies were obtained from eight subjects, four from each 
group, for histological analyses of both periorbital areas 
before and after the two-month-treatment period. 
2.3. Assessment of Clinical Effects 
Before treatment and after one and two months of treat- 
ment, digital photographs were taken of each patient us- 
ing identical camera settings and lighting conditions. 
Two dermatologists, blinded to the patient’s treatment, 
evaluated clinical improvements by studying these pho- 
tographs, and the participants themselves subjectively 
evaluated improvements at the same time points. Both 
patients and clinicians followed a five-point grading 
scale: 0 = no improvement, 1 = 1% − 25%, 2 = 26% − 
50%, 3 = 51% − 75%, 4 = 76% − 100% improvement.  
We used silicone casts (ReplicaTM, Cuderm Inc., Dal- 
las, TX, USA) of the participants’ periorbital wrinkles to 
assess skin texture before and after the two-month treat-
ment period. An adhesive ring locator was placed against 
the periorbital area and filled with pre-mixed resin so that 
the resin overflowed 2 - 3 mm onto the cardboard surface. 
After the resin set and the cast was peeled from the skin 
surface, the foam adhesive spacer layer was separated 
from the cardboard frame and discarded. The casts were 
labeled with the date, initials and group and stored in a 
paper envelope until analysis. For analysis, a collimated 
light source was directed at a 25˚ angle from the plane of 
 
Table 1. Compositions of the test and placebo solutions. 
Ingredients (gm/30 ml) Group A (collagen + adenosine) Group B (collagen) Group P (placebo) 
Sodium hyaluronate 0.12 0.12 0.12 
L-lysine 0.00006 0.00006 0.00006 
Succinylated atelocollagen 0.12 0.12 - 
Adenosine 0.012 - - 
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the cast surface. Each cast was placed in a holder that 
fixed the direction of the tab position of the cast. 
The textures of shadows produced by oblique lighting 
of the negative casts were analyzed via two assay meth-
ods. The first method involved measuring the luminance 
along a set of 10 equal-length parallel lines (passes) run-
ning across the cast parallel to the lighting direction. 
Variations in luminance were treated as indicators of 
surface roughness Rz, the average maximum difference 
in the luminance value for five equal-length segments in 
each of the ten lines traversing the sample; and Ra, the 
average deviation of the luminance curve about the mean 
luminance for the same ten lines, with “R” parameters 
reported in units of brightness (gray levels) ranging from 
0 to 255 and increase with increasing roughness; FNum, 
number markers indicative of fine and coarse lines per 
mm; and IDL, the integrated developed length of the 
luminance traces of the ten scan lines. The IDL is the 
total length of the luminance lines as a proportion of the 
straight-line distance and it increases with the roughness 
of the surface. For the second assay method, the cast im-
age area was divided into ten equal width bands or sub- 
areas. Shadow-like features were distinguished in each of 
these bands when their luminance values were less than 
the detection threshold. Four parameters were determined 
from the detected features: spacing, or the mean distance 
in millimeters between adjacent detected features, which 
increases with disappearance of wrinkles; breadth, or the 
average breadth of the detected features in millimeters, 
which is proportional to the depth of the wrinkles pro-
ducing shadows and decreases as wrinkles become shal-
lower; shadows, or the percent of the sampled replica 
area with luminance values less than the detection 
threshold, which the relative area of shadow cast by the 
wrinkles in the cast (shadows decrease with smoothing of 
the skin); and NumWr, or the total number of shadowy 
features detected in the ten bands or sub-areas, which 
decreases with smoothing of the skin.  
2.4. Assessment of Histological Changes  
Skin biopsies were taken from eight volunteers before 
treatment and after the two-month-treatment period using 
a 3 mm biopsy punch. At the first visit, specimens were 
obtained from crow’s feet at a 1.5 cm distance from the 
lateral margin of both eyes. The biopsies performed after 
the two-month-treatment period were taken directly next 
to the previous biopsy sites. The specimens were fixed in 
formalin and embedded in paraffin. Skin samples were 
stained with hematoxylin and eosin to measure the epi-
dermal thickness, Masson trichrome to evaluate changes 
in dermal collagen, monoclonal anti-human procollagen 
type I antibody (Abcam Inc., Cambridge, MA, USA) to 
demonstrate changes in collagen formation and mono-
clonal anti-human Ki-67 antibody (Abcam Inc.) to eva- 
luate changes in cellular proliferation in the skin. Images 
of each section were taken at a magnification of X200 
with a 12.5 megapixel digital camera (DP70, Olympus 
Optical Co., Tokyo, Japan) connected to a light micro-
scope (BX40, Olympus Optical Co.). The images were 
analyzed by MetaMorph (Molecular Devices, Sunnyvale, 
CA, USA). 
2.5. Statistical Analysis 
Statistical analysis was performed using the Wilcoxon 
signed-rank and rank-sum tests for evaluation of objec-
tive and subjective improvement scores and histological 
changes. One sample t-test and an independent group 
t-test were used to evaluate changes in the casts. P-values 
less than 0.05 were considered statistically significant 
and P-values less than 0.10 were considered directionally 
significant. 
3. Results 
3.1. Degree of Clinical Improvement  
Twenty-eight of 32 participants completed the two- 
month study. Four patients dropped out for personal rea-
sons without experiencing any side effects. The numbers 
of patients in each group were 15, 13 and 28 in groups A, 
B and P respectively. The mean clinical improvement 
scores, evaluated by two blinded dermatologists, at the 
one-month treatment assessment were 1.53 ± 0.64, 1.08 ± 
0.86 and 0.57 ± 0.50 in groups A, B and P respectively. 
The mean clinical improvement scores at the two-month 
treatment assessment were 2.27 ± 0.96, 2.31 ± 1.25 and 
0.96 ± 0.74 in groups A, B and P respectively (Figure 1). 
A significant difference in clinical improvement was 
observed between groups A and P (P = 0.0005), but we 
did not observe a significant difference between groups 
B and P at the one-month treatment assessment (P > 
 
 
Figure 1. Mean clinical improvement scores assessed by 
physicians (grading scale: 0 = no improvement, 1 = 1% - 
25%, 2 = 26% - 50%, 3 = 51% - 75%, 4 = 76% - 100% im- 
provement). 
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0.05). Significant differences were observed between 
groups A and P, and between groups B and P at the two- 
month treatment assessment (P = 0.0005, P = 0.0039). 
There were no significant differences between groups A 
and B at the one-month or two-month treatment assess-
ments (P > 0.05).  
The improvement scores assessed by the physicians 
and by participants were similar (Figure 2). However, at 
the one-month treatment assessment, no significant dif-
ferences were observed among the three groups (P > 0.05) 
by patients. At the two-month treatment assessment, par-
ticipant evaluations were significantly different between 
groups A (Figure 3) and P (Figure 4) (P = 0.01), and 
between groups B (Figure 5) and P (P = 0.001). There 
were no significant differences between groups A and B 
at the two-month treatment assessment (P > 0.05). The 
 
 
Figure 2. Mean clinical improvement scores assessed by 
participants (grading scale: 0 = no improvement, 1 = 1% - 
25%, 2 = 26% - 50%, 3 = 51% - 75%, 4 = 76% - 100% im- 
provement). 
 
 
Figure 3. Comparison of clinical improvement of periorbi- 
tal wrinkles and cast images of representative subject in 
group A before treatment (a) and two months after the 
treatment (b). Cast images before treatment (c) and two 
months after the treatment (d). 
 
Figure 4. Comparison of clinical improvement of periorbi- 
tal wrinkles and cast images of representative subject in 
group P before treatment (a) and two months after the 
treatment (b). Cast images before treatment (c) and two 
months after the treatment (d). 
 
 
Figure 5. Comparison of clinical improvement of periorbi- 
tal wrinkles and cast images of representative subject in 
group B before treatment (a) and two months after the 
treatment (b). Cast images before treatment (c) and two 
months after the treatment (d). 
 
treatments were well tolerated and there were no re-
markable complications for any of the participants.  
3.2. Cast Image Analysis 
A total of 112 casts were evaluated. The casts repre-
sented treated sites for groups A and B, and placebo sites 
for group P at two visit times: baseline (BL) and after the 
two-month treatment period (V2). The results are sum-
marized in Table 2. Changes from baseline were calcu-
lated by subtracting each subject’s BL values from the 
appropriate V2 values. Table 3 summarizes the mean 
changes from baseline for groups A, B and P. Changes 
from baseline were significant for three measured pa-  
Copyright © 2013 SciRes.                                                                               JCDSA 
The Efficacy and Safety of Succinylated Atelocollagen and Adenosine for the Treatment of Periorbital Wrinkles 
Copyright © 2013 SciRes.                                                                               JCDSA 
238 
 
Table 2. The results of cast image analysis at baseline (BL) and after two months of treatment (V2) (Group A, succinylated 
atelocollagen + adenosine; group B, succinylated atelocollagen; group P, placebo). 
 Group A Group B Group P 
 BL V2 BL V2 BL V2 
Rz 128.7 ± 38.0 109.6 ± 23.9 139.5 ± 32.6 113.0 ± 28.5 144.7 ± 24.2 126.8 ± 32.7 
Ra 24.5 ± 8.2 19.7 ± 4.9 26.9 ± 8.3 20.5 ± 6.5 27.9 ± 6.1 24.3 ± 7.1 
FNum 0.476 ± 0.093 0.439 ± 0.113 0.399 ± 0.098 0.386 ± 0.109 0.469 ± 0.112 0.469 ± 0.111 
IDL 6.95 ± 2.64 5.48 ± 1.55 6.84 ± 2.00 5.28 ± 1.67 6.93 ± 1.49 5.88 ± 1.66 
Spacing 1.948 ± 1.381 1.946 ± 1.053 1.840 ± 1.259 2.239 ± 1.177 1.389 ± 0.325 2.005 ± 1.288 
Breadth 0.188 ± 0.030 0.198 ± 0.042 0.247 ± 0.058 0.206 ± 0.042 0.222 ± 0.043 0.216 ± 0.039 
Shadows 4.2 ± 3.6 3.1 ± 2.0 5.4 ± 3.7 2.7 ± 2.7 5.8 ± 3.8 4.4 ± 3.2 
NumWr 71.5 ± 52.4 57.3 ± 35.6 73.7 ± 40.3 46.4 ± 43.9 83.3 ± 36.1 72.1 ± 47.7 
 
Table 3. Mean changes from baseline in groups A, B and P, and treatment effects calculated by subtracting value of group P 
from value of group A or B. (Group A; succinylated atelocollagen + adenosine, group B; succinylated atelocollagen, group P; 
placebo.). 
 Mean changes from baseline Treatment effects 
 Group A Group B Group P Group A Group B 
 Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
Rz −19.1 ± 40.5** −26.5 ± 37.1* −17.8 ± 27.7* 9.2 ± 51.4 −20.8 ± 41.3** 
Ra −4.8 ± 8.4* −6.4 ± 8.2* −3.6 ± 6.5* 1.1 ± 10.5 −5.3 ± 9.0** 
FNum −0.038 ± 0.096 −0.014 ± 0.117 0.001 ± 0.089 −0.035 ± 0.129 −0.018 ± 0.134 
IDL  −1.47 ± 2.80** −1.56 ± 2.82** −1.04 ± 1.59* 0.33 ± 3.11 −1.39 ± 2.85 
Spacing −0.002 ± 1.665 0.372 ± 1.768 0.623 ± 1.193* −0.615 ± 2.188 −0.334 ± 1.978 
Breadth 0.01 ± 0.056 −0.041 ± 0.059* −0.006 ± 0.045 0.008 ± 0.063 −0.026 ± 0.069 
Shadows −1.1 ± 4.0 −2.7 ± 3.3* −1.4 ± 3.2* 0.3 ± 4.3 −1.2 ± 2.8 
NumWr −14.1 ± 57.2 −27.3 ± 48.2** −11.2 ± 42.0 −4.1 ± 66.3 −14.8 ± 49.4 
*P < 0.05, **P < 0.10. 
 
rameters in Group A (Figure 3) and six parameters in 
Group B (Figure 5). The changes for both groups repre-
sented improvements in texture (increased smoothness), 
with decreases from baseline for Rz, Ra and IDL (both 
groups A and B), Breadth, Shadows and NumWr (Group 
B only). In group P, changes from baseline were signifi-
cant for five measured parameters (Figure 4). The 
changes represented improvements in texture: decreases 
from baseline for Rz, Ra, IDL and Shadows parameters, 
with an increase in the Spacing parameter.  
Similarly, the differences between treated and placebo 
site pairs (treatment effects) were calculated by subtract-
ing the appropriate baseline corrected values for each 
subject. These results are shown in Table 3. Treatment 
effects were directionally significant for two parameters 
for group B only. Significant treatment effects for Rz and  
Ra were in the direction of active smoother compared to 
group P. 
Groups A and B were also compared. A direct com-
parison of group A and B treatment effects confirmed 
that the differences in Ra parameters between groups 
were directionally significant, with group B smoother 
than group A (P = 0.0923). 
3.3. Histological Changes 
Changes in histological features between baseline and 
after two months of treatment are shown in Table 4. 
Changes from baseline were calculated by subtracting 
each subject’s BL values from the V2 values. 
Epidermal thickness increased after two months of 
treatment compared with val es before treatment in all  u  
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Table 4. Quantitative changes in histological features between baseline and after two months of treatment. (Group A; suc-
cinylated atelocollagen + adenosine, group B; succinylated atelocollagen, group P; placebo.). 
Change Group A Group B Group P 
Epidermal thickness (μm) 10.23 ± 7.60 13.15 ± 5.65 6.96 ± 10.15 
Collagen (OD) 707.07 ± 1354.46 873.87 ± 331.01 756.72 ± 476.35 
Ki-67 (OD) 224.28 ± 102.03* 181.49 ± 283.44 −102.47 ± 266.31 
Procollagen type I (OD) 346.29 ± 570.80 406.87 ± 665.45 529.29 ± 618.73 
OD, optical density. *P < 0.05. 
 
groups. The periorbital areas treated with succinylated 
atelocollagen and adenosine containing solution or only 
succinylated atelocollagen containing solution showed 
greater increases in epidermal thickness. However, there 
were no significant differences among the three groups 
(P > 0.05). 
Quantitative image analyses of pre- and post-treatment 
biopsies revealed that after the two-month treatment pe- 
riod, the quantities of collagen fibers of each group had 
increased compared with baseline (Table 4). However, 
there were no significant differences among the three 
groups (P > 0.05). 
Quantitative image analyses of Ki-67 expression on 
pre- and post-treatment biopsies showed an increase after 
the two-month treatment period in groups A and B. 
However, there was a decrease in the optical density of 
Ki-67 expression in group P (Table 4). There was a sig- 
nificant difference between groups A and P (P = 0.0455), 
but there were no significant differences between groups 
A and B or between groups B and P (P > 0.05) (Figure 
6). 
Immunohistochemical staining of procollagen type I 
expression revealed that procollagen expression was in-
creased in all groups. Quantitative analyses of procolla-
gen type I expression showed that the changes from 
baseline were 346.3 ± 570.8, 406.9 ± 665.5 and 529.3 ± 
618.7 in groups A, B, and P respectively. However, there 
were no significant differences among the three groups 
(P > 0.05). 
4. Discussion 
Wrinkle formation represents both photoaging and chro- 
nological aging. Periorbital wrinkles are generated early 
in the formation of wrinkles. At the molecular level, ul-
traviolet (UV) irradiation activates cytokine receptors 
and other growth factors on the surface of fibroblasts and 
keratinocytes. Activated receptors and growth factors 
stimulate transcription factor AP-1 through a signal 
transduction cascade, and AP-1 stimulates the transcrip-
tion of matrix metalloproteinase (MMP) genes. MMPs 
break down collagen, the main component of the dermal 
extracellular matrix, and other structural proteins [2]. The  
 
Figure 6. Immunohistochemical staining of Ki-67 expres-
sion (original magnification X200). (a) Before treatment 
and (b) after two months of treatment using succinylated 
atelocollagen and adenosine-containing solution; (c) before 
treatment and (d) after two months of treatment using suc-
cinylated atelocollagen-containing solution; (e) before treat- 
ment and (f) after two months of treatment using placebo 
solution. 
 
activation of MMP-1 and MMP-9 leads to the partial 
degradation of collagen, which regulates procollagen 
type I synthesis and down-regulates procollagen type I 
formation [9]. AP-1 stimulated by UV irradiation also 
interferes with collagen synthesis through down-regu- 
lation of procollagen type I gene expression [10]. Colla-
gen provides skin with its tensile strength, so the degra-
dation of structural collagen and reduced collagen syn-
thesis are likely to be major contributors to the charac-
teristic appearance of wrinkles [11]. In chronological 
aging, molecular features similar to those in photoaging 
have been identified [2]. 
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As mentioned above, some substances have been 
proven to repair and prevent wrinkles. Many controlled 
studies have demonstrated that topical applications of 
retinoids reduce the severity of wrinkles [12]. All-trans- 
retinoic acid, a first-generation retinoid, induces produc-
tion of procollagen types I and III through induction of 
TGF-β, a key player in fibroblast collagen synthesis [11]. 
Increases in levels of collagen types I and III provide 
resiliency and strength to skin. Another constituent, 
adenosine, has also been shown to be effective in treating 
wrinkles [13]. Adenosine acts as a regulator of cellular 
and organ function, and interacts with a family of 4G 
protein-coupled receptors, A1, A2A, A2B and A3. After 
binding to A2A receptors, collagen production is stimu- 
lated by fibroblasts via a MEK-1/MAPK-mediated path- 
way and collagen degradation is reduced by down-regu- 
lation of MMP expression [14]. 
Increased collagen synthesis and decreased collagen 
degradation are the keystones of strategies for preventing 
or improving the appearance of wrinkles. However, there 
are no reported clinical studies that evaluate the effect of 
topical collagen on periorbital wrinkles. Collagen en- 
hances the attachment and proliferation of fibroblasts 
[15]. Fibroblasts bind to intact collagen fibrils via cell 
surface integrin receptors and this binding creates dy- 
namic mechanical tension within fibroblasts and main-
tains their shape. Mechanical tension and cell shape are 
critical for proper cellular function and the synthesis of 
procollagen fibrils [7]. Recently, there has been an in- 
crease in the use of collagen for the treatment of chronic 
wounds [16]. 
In this study, we investigated the efficacy of topical 
application of succinylated atelocollagen-containing so- 
lution and compared these effects with the effects of 
adenosine on periorbital wrinkles. The succinylated ate- 
locollagen-containing solution that we tested was com-
posed of succinylated atelocollagen, L-lysine, sodium 
hyaluronate and purified water. The size of the suc- 
cinylated atelocollagen molecule is 300 nm × 2.4 nm. 
The telopeptide consists of 12 - 27 amino acids in a col- 
lagen molecule, and the sequence of the telopeptide is 
different between individuals. Complete removal of the 
telopeptide helps prevent immune reactions and reduces 
the size of the molecule [17]. Succinylated atelocollagen 
was treated with succinic anhydride to create an electri- 
cally anionic surface that improves solubility in water or 
neutral solution. L-lysine has been widely used as a cell 
adhesion agent and mediator for drug delivery. Because 
L-lysine has polycationic sites, it adheres to anionic sites 
on the cell surface and the succinylated atelocollagen. 
Therefore, combining the succinylated atelocollagen with 
L-lysine increases skin penetration. Brown et al. [18] 
showed that hyaluronic acid, which has hydrophilic 
properties and a large molecular weight (360 - 400 kDa), 
can be absorbed from the surface of intact skin by pas- 
sive diffusion and active transport and be observed in the 
deeper layers of epidermis and dermis. Succinylated ate- 
locollagen has better solubility and similar molecular 
weight so it may be absorbed through intact human skin. 
Hyaluronic acid is also a component of the extracellular 
matrix and has the ability to induce fibroblasts to prolif- 
erate and to produce more collagen [19]. In addition, 
succinylated atelocollagen and hyaluronic acid can hold 
water within their molecules. Interspersed water has a 
bulking effect and may improve periorbital wrinkles.  
Based on the objective measurements of clinical im-
provement, groups A and B showed more significant im- 
provement than group P after a two-month treatment 
period. However, we did not observe any significant ef-
fects after two months of adenosine treatment. The sub-
jective assessments of improvement by the participants 
were similar to the objective assessments of clinical im-
provement. In the analysis of the casts, the treated sites 
for both groups A and B exhibited consistent smoothing 
of the periorbital wrinkles. In paired comparisons with 
group P, only group B showed directionally significant 
improvement for two parameters of roughness. Although 
the differences were not statistically significant, other 
parameters were in the direction of active smoother 
compared to group P. It was confirmed that only one 
parameter of roughness (Ra) in group B was lower than 
in Group A (P = 0.0923). Overall, the results suggest that 
the treatment effect in group B was somewhat superior to 
the effects in groups A or P. 
Analysis of histological features revealed increased 
epidermal thickness, collagen and procollagen type I 
density with treatment in all groups. There were no sig-
nificant differences among the three groups. The density 
of Ki-67 in group A was significantly higher than that of 
group P. Ki-67 protein is a cellular marker for prolifera-
tion and can be exclusively detected within the cell nu-
cleus during interphase [20]. It is thought that adenosine, 
which was included in group A’s treatment, may affect 
the proliferation of keratinocytes. However, we did not 
observe proliferation of dermal fibroblasts with Ki-67 
staining. This may be due to the short treatment time or 
the low penetration rate of the treatment solution. We 
were not able to distinguish the effects of succinylated 
atelocollagen or adenosine on histological features. The 
lack of significant differences among the three groups 
may be due to the small number of subjects (each group, 
n = 4) and relatively short duration of treatment. 
Although degree of clinical improvement showed anti- 
wrinkle efficacy of succinylated atelocollagen, the objec- 
tive measures such as cast image analysis and histology- 
cal changes did not support it sufficiently. Analysis of 
cast images showed significant improvement on some 
parameters between the areas treated with succinylated 
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atelocollagen-treated and the areas treated with placebo. 
However, we did not observe any effects of adenosine on 
periorbital wrinkles. This may be due to the small num- 
ber of subjects or to the short treatment period.  
5. Conclusion 
The results of our study show that succinylated atelo- 
collagen may be an effective treatment option for perior- 
bital wrinkles, but further studies with a longer treatment 
period and larger subject group are needed to verify these 
results. 
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